BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26602202)

  • 1. Late diagnosis of Fabry disease caused by a de novo mutation in a patient with end stage renal disease.
    Pisani A; Daniele A; Di Domenico C; Nigro E; Salvatore F; Riccio E
    BMC Res Notes; 2015 Nov; 8():711. PubMed ID: 26602202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo mutation in a male patient with Fabry disease: a case report.
    Iemolo F; Pizzo F; Albeggiani G; Zizzo C; Colomba P; Scalia S; Bartolotta C; Duro G
    BMC Res Notes; 2014 Jan; 7():11. PubMed ID: 24398019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early renal failure in childhood in a male with Fabry disease.
    Hogh JN; Ebrahim H; Moochhala S; Ramaswami U
    BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35537774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fabry disease presenting as apical left ventricular hypertrophy in a patient carrying the missense mutation R118C.
    Caetano F; Botelho A; Mota P; Silva J; Leitão Marques A
    Rev Port Cardiol; 2014 Mar; 33(3):183.e1-5. PubMed ID: 24661928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic renal failure and proteinuria in adulthood: Fabry disease predominantly affecting the kidneys.
    Cybulla M; Schaefer E; Wendt S; Ling H; Kröber SM; Hövelborn U; Schandelmaier S; Rohrbach R; Neumann HP
    Am J Kidney Dis; 2005 May; 45(5):e82-9. PubMed ID: 15861341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabry disease in patients with end-stage renal failure: the potential benefits of screening.
    Bekri S; Enica A; Ghafari T; Plaza G; Champenois I; Choukroun G; Unwin R; Jaeger P
    Nephron Clin Pract; 2005; 101(1):c33-8. PubMed ID: 15886492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous multicystic kidney and Anderson-Fabry disease: 2 separate entities or same side of the coin.
    Pisani A; Riccio E; Cianciaruso B; Imbriaco M
    J Nephrol; 2011; 24(6):806-8. PubMed ID: 22058028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No accumulation of globotriaosylceramide in the heart of a patient with the E66Q mutation in the α-galactosidase A gene.
    Kobayashi M; Ohashi T; Fukuda T; Yanagisawa T; Inomata T; Nagaoka T; Kitagawa T; Eto Y; Ida H; Kusano E
    Mol Genet Metab; 2012 Dec; 107(4):711-5. PubMed ID: 23146289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabry disease. A case report.
    Kotnik J; Kotnik F; Desnick RJ
    Acta Dermatovenerol Alp Pannonica Adriat; 2005 Mar; 14(1):15-9. PubMed ID: 15818441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Japanese patients with Fabry disease predominantly showing cardiac and neurological manifestation with novel missense mutation: R220P.
    Fukutomi M; Tanaka N; Uchinoumi H; Kanemoto M; Nakao F; Yamada J; Kamei T; Takenaka T; Fujii T
    J Cardiol; 2013 Jul; 62(1):63-9. PubMed ID: 23608164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabry disease with cardiovascular manifestation in a patient with end-stage renal disease.
    Skopcová H; Dostálová G; Paleček T; Linhart A; Honsová E
    Cesk Patol; 2021; 57(1):49-52. PubMed ID: 33910349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple parapelvic cysts in Fabry disease.
    Azancot MA; Vila J; Domínguez C; Serres X; Espinel E
    Nefrologia; 2016; 36(3):310-2. PubMed ID: 27061865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel α-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease.
    Duro G; Musumeci MB; Colomba P; Zizzo C; Albeggiani G; Mastromarino V; Volpe M; Autore C
    Gene; 2014 Feb; 535(2):365-9. PubMed ID: 24140492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype.
    Nakao S; Kodama C; Takenaka T; Tanaka A; Yasumoto Y; Yoshida A; Kanzaki T; Enriquez AL; Eng CM; Tanaka H; Tei C; Desnick RJ
    Kidney Int; 2003 Sep; 64(3):801-7. PubMed ID: 12911529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A boy with Fabry disease with the onset at the age of four].
    Liu YP; Huang Y; Wang Q; Wu TF; Ma YY; Li XY; Song JQ; Yang YL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):307-11. PubMed ID: 23591357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel alpha-galactosidase a mutant (M42L) identified in a renal variant of Fabry disease.
    Rosenthal D; Lien YH; Lager D; Lai LW; Shang S; Leung N; Fervenza FC
    Am J Kidney Dis; 2004 Nov; 44(5):e85-9. PubMed ID: 15492942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Two cases of heterozygous Fabry disease].
    Shibuya Y; Oku N; Suzuki Y; Gomi T
    Nihon Jinzo Gakkai Shi; 2006; 48(5):421-7. PubMed ID: 16913464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a nationwide screening for Anderson-Fabry disease among dialysis patients.
    Kotanko P; Kramar R; Devrnja D; Paschke E; Voigtländer T; Auinger M; Pagliardini S; Spada M; Demmelbauer K; Lorenz M; Hauser AC; Kofler HJ; Lhotta K; Neyer U; Pronai W; Wallner M; Wieser C; Wiesholzer M; Zodl H; Födinger M; Sunder-Plassmann G
    J Am Soc Nephrol; 2004 May; 15(5):1323-9. PubMed ID: 15100373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for Fabry disease in left ventricular hypertrophy: documentation of a novel mutation.
    Baptista A; Magalhães P; Leão S; Carvalho S; Mateus P; Moreira I
    Arq Bras Cardiol; 2015 Aug; 105(2):139-44. PubMed ID: 26269958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic DNA Study for Fabry Disease in the End Stage Renal Disease Patients from a Southern Italy Area.
    Zizzo C; Testa A; Colomba P; Postorino M; Natale G; Pini A; Francofonte D; Cammarata G; Scalia S; Sciarrino S; Zoccali C; Duro G
    Kidney Blood Press Res; 2018; 43(4):1344-1351. PubMed ID: 30099469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.